Softwr

Healthcare · head to head

Meru Health vs PathAI

Meru Health logo

Meru Health

Healthcare

Twelve week therapist led mental health programme combining an app, a clinician and HRV biofeedback

From
On request
Rated
-
Full reviewWebsite
PathAI logo

PathAI

Healthcare

Digital pathology image management with an FDA cleared platform for primary diagnosis

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Meru Health the programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.; PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • They diverge on capability: Meru Health covers Twelve week structured programme, PathAI covers AISight image management.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Meru Health and PathAI actually diverge.

Attributes where Meru Health and PathAI differ
AttributeMeru HealthPathAI
PlatformsWeb, iOS, AndroidWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Meru Health

  • Twelve week structured programme
  • Licensed therapist
  • Psychiatric consultation
  • HRV biofeedback device
  • Daily in app practice
  • Meru Health Advanced
  • Payer contracting
  • Outcome measurement

Only in PathAI

  • AISight image management
  • AISight Dx
  • Scanner interoperability
  • Case and worklist management
  • AI algorithm deployment
  • Biopharmaceutical research tooling
  • LIS integration

What people use each for

The jobs each tool is most often brought in to do.

Meru Health

  • A health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefitnot PathAI
  • An employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathwaynot PathAI
  • A member who needs medication review alongside therapy, which most app based mental health products cannot providenot PathAI
  • A health system seeking to offload moderate depression and anxiety from a psychiatry service with long waitsnot PathAI

PathAI

  • An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot Meru Health
  • A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot Meru Health
  • A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot Meru Health
  • A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot Meru Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Meru Health

  • The programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.
  • Whether the employer, the health plan or the member pays depends on the contract route, and members frequently do not know which applies to them until they receive a bill or discover they do not.
  • A structured programme demands daily engagement, and members who cannot sustain that get much less than the outcome data implies, because the published results reflect members who completed.
  • The heart rate variability device is a differentiator but also a logistics and support burden, adding shipping, returns and device support to what would otherwise be a software deployment.
  • Meru is small relative to Lyra, Spring Health and the large payer owned behavioural health offerings, so an employer choosing it takes on more vendor concentration risk in a category that has seen frequent consolidation.

PathAI

  • AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
  • Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
  • Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
  • PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.

Pricing, plan by plan

Meru Health

On request
  • Meru Health$undefined/year
    • Contracted per completed programme or per member per month depending on buyer type
    • Health plan contracts bill differently from employer contracts
    • Member cost sharing depends on whether access comes via insurance or an employer benefit

PathAI

On request
  • AISight$undefined/year
    • Priced by annual slide or case volume and by pathologist seats
    • AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
    • Image storage priced by capacity and retention policy

Which should you pick?

Choose Meru Health if

  • You need twelve week structured programme.
  • You work on Web, iOS, Android.
  • You also want licensed therapist.
Meru Health review

Choose PathAI if

  • You need aisight image management.
  • You also want aisight dx.
PathAI review

Questions people ask

Is Meru Health or PathAI better?
Neither clearly leads. Meru Health starts at On request and PathAI at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Meru Health or PathAI?
Meru Health starts at On request and PathAI at On request.
Does Meru Health or PathAI run on more platforms?
Meru Health runs on Web, iOS, Android. PathAI runs on Web.
What is Meru Health best used for?
Meru Health is most often used for a health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefit, an employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathway, a member who needs medication review alongside therapy, which most app based mental health products cannot provide, a health system seeking to offload moderate depression and anxiety from a psychiatry service with long waits. Of those, a health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefit and an employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathway are not what PathAI is typically brought in for.
What can Meru Health do that PathAI cannot?
Meru Health covers Twelve week structured programme, Licensed therapist, Psychiatric consultation, HRV biofeedback device. PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management.

Answered from the vendors’ own pages

Meru Health: Is Meru Health still operating?

Yes. It launched Meru Health Advanced in May 2026 and expanded its Harvard Pilgrim Health Care collaboration in 2025. It has not wound down.

PathAI: What is the difference between AISight and AISight Dx?

AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.

Meru Health: How long is the programme?

Around twelve weeks. It is a bounded treatment episode rather than open ended therapy, which is why health plans will contract for it.

PathAI: Can we use our existing scanners?

Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.

Meru Health: Who pays?

It depends on the contract. Meru sells to both health plans and employers, and member cost sharing differs between those routes. Confirm which applies before enrolling.

PathAI: Do the AI algorithms carry the same clearance as the platform?

No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.

Meru Health: Does it include medication?

Psychiatric consultation is part of the programme where medication is indicated, which distinguishes it from app plus coaching products that cannot prescribe.

PathAI: Is pricing published?

No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.

Share

Related pages

More on Meru Health

More on PathAI

Keep looking

Other head to heads